Immediate Impact
1 from Science/Nature 60 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
2024 Standout
Works of S. Petrykiv being referenced
Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
2018
Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| S. Petrykiv | 407 | 211 | 220 | 27 | 521 | |
| Cheli Melzer Cohen | 417 | 151 | 123 | 30 | 499 | |
| Josselin Nespoux | 319 | 213 | 177 | 13 | 465 | |
| Muralikrishna Gangadharan Komala | 346 | 160 | 213 | 20 | 585 | |
| Brent Freeman | 325 | 247 | 168 | 12 | 484 | |
| Gary K. Yang | 362 | 351 | 115 | 28 | 618 | |
| Conxita Jacobs-Cachá | 165 | 87 | 218 | 23 | 537 | |
| Komuraiah Myakala | 263 | 183 | 213 | 17 | 559 | |
| Emil List Larsen | 275 | 177 | 89 | 32 | 533 | |
| Ana Elena Rodríguez‐Rodríguez | 176 | 194 | 113 | 29 | 518 | |
| Stephanie Franzén | 194 | 148 | 154 | 24 | 477 |
All Works
Loading papers...